The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers

BACKGROUND: The inflammatory cascade is the main cause of death in COVID-19 patients. Corticosteroids (CS) and tocilizumab (TCZ) are available to treat this escalation but which patients to administer it remains undefined. OBJECTIVE: We aimed to evaluate the efficacy of immunosuppressive/anti-inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio-Rivas, Manuel, Mora-Luján, José M., Montero, Abelardo, Aguilar García, Josefa Andrea, Méndez Bailón, Manuel, Fernández Cruz, Ana, Oriol, Isabel, Teigell-Muñoz, Francisco-Javier, Dendariena Borque, Beatriz, De la Peña Fernández, Andrés, Fernández González, Raquel, Gil Sánchez, Ricardo, Fernández Fernández, Javier, Catalán, Marta, Cortés-Rodríguez, Begoña, Mella Pérez, Carmen, Montero Rivas, Lorena, Suárez Fuentetaja, Rebeca, Ternero Vega, Jara Eloísa, Ena, Javier, Martin-Urda Díez-Canseco, Anabel, Pérez García, Cristina, Varona, José F., Casas-Rojo, José Manuel, Millán Núñez-Cortés, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523009/
https://www.ncbi.nlm.nih.gov/pubmed/34664188
http://dx.doi.org/10.1007/s11606-021-07146-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523009/
https://www.ncbi.nlm.nih.gov/pubmed/34664188
http://dx.doi.org/10.1007/s11606-021-07146-0

Ejemplares similares